Kit pos cardiac progenitor cells (CPCs) represent a successful approach in healing the infarcted heart and rescuing its mechanical function, but electrophysiological consequences are uncertain. CPC mobilization promoted by hepatocyte growth factor (HGF) and IGF-1 improved electrogenesis in myocardial infarction (MI). We hypothesized that locally delivered CPCs supplemented with HGF ϩ IGF-1 (GFs) can concur in ameliorating electrical stability of the regenerated heart. Adult male Wistar rats (139 rats) with 4-wk-old MI or sham conditions were randomized to receive intramyocardial injection of GFs, CPCs, CPCs ϩ GFs, or vehicle (V). Enhanced green fluorescent protein-tagged CPCs were used for cell tracking. Vulnerability to stress-induced arrhythmia was assessed by telemetry-ECG. Basic cardiac electrophysiological properties were examined by epicardial multiple-lead recording. Hemodynamic function was measured invasively. Hearts were subjected to anatomical, morphometric, immunohistochemical, and molecular biology analyses. Compared with V and at variance with individual CPCs, CPCs ϩ GFs approximately halved arrhythmias in all animals, restoring cardiac anisotropy toward sham values. GFs alone reduced arrhythmias by less than CPCs ϩ GFs, prolonging ventricular refractoriness without affecting conduction velocity. Concomitantly, CPCs ϩ GFs reactivated the expression levels of Connexin-43 and Connexin-40 as well as channel proteins of key depolarizing and repolarizing ion currents differently than sole GFs. Mechanical function and anatomical remodeling were equally improved by all regenerative treatments, thus exhibiting a divergent behavior relative to electrical aspects. Conclusively, we provided evidence of distinctive antiarrhythmic action of locally injected GF-supplemented CPCs, likely attributable to retrieval of Connexin-43, Connexin-40, and Cav1.2 expression, favoring intercellular coupling and spread of excitation in mended heart. cardiac progenitor cells; growth factors and cytokines; myocardial infarction; arrhythmia; cardiac gap junction connexins
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NEW & NOTEWORTHY

Repair of infarcted heart by local injection of c-kit pos cardiac progenitors supplemented with hepatocyte growth factor and IGF-1 has distinctive antiarrhythmic effects involving recovery of Connexin-43, Connexin-40, and Ca v1.2 expression levels differently than progenitors or cytokines alone. This new insight into the impact of regenerative therapies on cardiac electrogenesis has clinical relevance.
HEART FAILURE (HF) very often proceeds as a consequence of myocardial infarction (MI) (59) and continues to be a major health problem (49) . Over the past 15 yr, cell therapy has emerged as a new strategy aimed at revitalizing dead myocardium, thus circumventing the unfavorable outcome of degenerative heart diseases, including the vicious circle of MI/HF (67) . However, results obtained so far in clinical trials with a large sample size using cells of different origin, mainly skeletal myoblasts (44) and bone marrow cells (78) , have been contradictory, with moderate or even no clinical benefits and, in the case of skeletal myoblasts, unwanted complications such as life-threatening arrhythmias. The adverse electrophysiological effects and the limited positive impact on cardiac repair decreased to date the interest in regenerative therapies mediated by skeletal myoblasts (67) . As for bone marrow cells, fresh meta-analysis data indicate that the treatment may be advantageous in people with chronic MI and HF, with minimal major intervention-related adverse effects and no increase in the incidence of arrhythmias (23) . However, although promising, these results appear to require further research involving larger, appropriately randomized clinical trials (23) .
In the last decade, increasing attention has been paid to resident cardiac progenitor cells as a novel target of cell therapy for ischemic cardiomyopathy and failing heart, based on the notion that the adult heart contains progenitors, which are intrinsically programmed to generate myocardium and therefore appear to be best suited for the complex task of reconstituting tissue that is lost with MI (14, 24, 37, 38, 51). By similar reasoning, stem cells of various origin and more easily harvested than cardiac progenitors, such as mesenchymal and pluripotent stem cells, could be oriented toward cardiac lineages and profitably adopted in clinical settings (45) . The initial results of two randomized phase 1 clinical trials (SCIPIO, NCT00474461 and CADUCEUS, NCT00893360), aimed at establishing the feasibility and safety of intracoronary injection of autologous cardiac-derived progenitors in patients with HF after MI, have been published in recent years (7, 42) . In the SCIPIO study (7) , the infusion of c-kit pos selected cells produced a remarkable improvement in both global and regional left ventricular (LV) function, reduced infarct size, and increased viable tissue. In the CADUCEUS study (42) , the administration of cardiosphere-derived cells markedly reduced scar mass and concurrently increased the viable heart mass, regional contractility, and regional systolic wall thickening. In both trials, the improvement in cardiac function persisted at least 1 yr, without any occurrence of major negative consequences attributable to the regenerative treatment. In a third trial (C-CURE, NCT00810238) (2), cardiopoietic stem cells, obtained after exposure of bone marrow-derived mesenchymal stem cells to a cardiogenic cocktail, were delivered to patients with HF of ischemic origin, by endomyocardial injections. Data collected at 6 mo from treatment demonstrated a favorable impact on myocardial remodeling, LV ejection fraction, and global wellness, without any evidence of increased cardiac or systemic toxicity and proarrhythmogenic risk.
By removing the loss of cardiac tissue as an underlying cause of HF, stem cell-based heart repair is expected to ameliorate both the contractile and the electrical competence of the healed myocardium. Of note, lethal arrhythmias are responsible for up to half of the deaths in HF (30) . On the contrary, the arrhythmic risk of implantation, homing, engraftment, and differentiation of regenerating cells within the damaged cardiac tissue has constantly been a reason for major concern in the clinical use (15, 17, 48, 73, 74) . Nevertheless, a number of papers documented a direct prorhythmic (rather than arrhythmic) action of cell therapy (11, 27, 34, 46, 50, 72, 89, 90, 92, 93) .
In preclinical studies, several cohorts of cardiogenic cells were characterized by different groups and considered involved in myocardial renewal (37, 67) . Among these populations, although the mechanism is questioned (22, 84) , c-kit pos cardiac progenitor cells repeatedly proved capable of rescuing scarred infarcted myocardium and ameliorating cardiac function (4, 5, 80) . Additionally, CPCs were reported to express c-Met and IGF-1 receptors and could be activated in situ via the corresponding ligands, hepatocyte growth factor (HGF), and IGF-1, promoting repopulation of the damaged heart (21, 33, 39, 64, 82) . Activation of CPCs was also obtained either by incubating the cells with HGF and IGF-1 before implantation, or by coinjecting the cells with the two growth factors (GFs) (63, 81) . Furthermore, in a rat model of chronic MI, we demonstrated that cardiac repair by local injection of HGF ϩ IGF-1 (GFs) was associated with a decline in proneness to arrhythmias, attributed to better intercellular coupling via increased expression of Connexin-43 (Cx43) and attenuation of negative remodeling (6) .
This body of observations formed the basis of the present study aimed at testing the hypothesis that intramyocardial injection of CPCs supplemented with GFs restores electrical function toward normal in the regenerated infarcted heart and also stressing the potential positive impact of GF adjunct on cardiac performance in cell therapy as well as the differences compared with sole GFs.
MATERIALS AND METHODS
Ethics Statement
The study was conducted in conformity with the American Physiological Society guiding principles in the care and use of vertebrate animals in research and training. The protocol was submitted to, and approved by, the Veterinary Animal Care and Use Committee of the University of Parma and adheres to the National Ethical Guidelines of the Italian Ministry of Health. All surgery was performed under anesthesia, and all animals received humane care.
Animals and Housing
The study population consisted of 157 male Wistar rats (Rattus norvegicus) bred in our departmental animal facility, aged 12-14 wk, weighing 350 -400 g, and kept under controlled housing conditions (5) .
All animals were subjected to either MI or sham operation (SO) and, 4 wk later, treated with GFs, CPCs, CPCs supplemented with GFs, or vehicle (V), representing the following eight groups: MI-GF, MI-CPC, MI-CPC ϩ GF, MI-V, SO-GF, SO-CPC, SO-CPC ϩ GF, and SO-V. Given that in preliminary studies ( Fig. 1 , A-E), cardiac electromechanical function assessed by vulnerability to arrhythmias and hemodynamic measurements had comparable values in the four SO groups, all so animals of the current study were pooled together and globally defined as SO treated (SO-T). V was normal saline (0.9% wt/vol of NaCl). Eighteen rats died in the perioperative period either before myocardial injection (SO rats, n ϭ 2, MI, n ϭ 7) or after (MI-V, n ϭ 4; MI-GF, n ϭ 2; MI-CPC, n ϭ 1; MI-CPC ϩ GF, n ϭ 2), leaving a total of 139 rats.
Outline of the Experimental Protocols
The experimental design and measurements performed in the various animal groups are summarized in Fig. 2 .
Telemetry-ECG, hemodynamics, cardiac anatomy, morphometry, and immunohistochemistry studies. Sixty-four rats were chronically instrumented with a telemetry-ECG system to enable the evaluation of arrhythmia vulnerability in conscious freely moving animals. One week later, a 30-min continuous baseline ECG was recorded to rule out the presence of spontaneous arrhythmias. Four weeks after MI (n ϭ 45) or SO (n ϭ 19), the animals were investigated for proneness to ventricular arrhythmias by telemetry-ECG recording in baseline condition and stress-induced autonomic stimulation (social stress procedure). All rats were then reoperated on and treated by intramyocardial injections of GFs, CPCs, CPCs ϩ GFs, or V (MI-GF group, n ϭ 12; MI-CPC group, n ϭ 11; MI-CPC ϩ GF, n ϭ 12; MI-V, n ϭ 10; SO-T, n ϭ 19). In some experiments, enhanced green fluorescent protein-tagged CPCs (GFP pos CPCs) were used for cell tracking. Additionally, selected subgroups of MI animals were chronically instrumented with an osmotic pump for continuous delivery of 5-bromo-2=-deoxycytidine (BrdC), which in vivo is metabolically converted to 5-bromo-2=-deoxyuridine (BrdU), to establish the cumulative amount of cell proliferation. Two weeks later, vulnerability to arrhythmias was redetermined by a new series of telemetry-ECG recordings. Afterward, hemodynamic data were invasively collected in all animals listed above and in a further 4 MI-GF, 7 MI-CPC, and 11 MI-CPC ϩ GF. Finally, at death, the heart was perfusion fixed for anatomical, structural, and immunohistochemical studies.
Epicardial multiple lead recording, qRT-PCR, and immunoblot studies. In 51 rats belonging to MI-GF (n ϭ 11), MI-CPC (n ϭ 11), MI-CPC ϩ GF (n ϭ 7), MI-V (n ϭ 12), or SO-T (n ϭ 10) groups, 2 wk after treatment, electrophysiological investigation was performed by epicardial multiple-lead recording. Sixty-four unipolar electrograms (EGs) were simultaneously collected from as many sites of the infarcted ϩ peri-infarcted epicardial area during sinus rhythm or specific pacing protocols to determine a series of electrophysiological parameters, allowing an in-depth characterization of ventricular electrical function. At death, fresh preparations of the excised heart were immediately frozen for qRT-PCR and immunoblot analyses, which were completed in two supplementary animals assigned to MI-CPC ϩ GF group.
Anesthesia and postinterventional treatment. Animals were anaesthetized with ketamine chloride (40 mg/kg ip; Imalgene; Merial, Milan, Italy) plus medetomidine hydrochloride (0.15 mg/kg ip; Domitor; Pfizer Italia, Latina, Italy) unless otherwise stated. Following the intervention, all animals were given atipamezole hydrochloride (0.15 mg/kg im; Antisedan, Pfizer Italia), flunixin (5 mg/kg im; Finadyne, Schering-Plough, Milan, Italy), and gentamicine sulphate (10 mg/kg im; Aagent; Fatro, Milan, Italy) and kept warm with infrared lamp radiation. Eventually, each rat was individually housed, and antibiotic therapy continued for the three subsequent days.
Inclusion criteria for MI and arrhythmias. Because arrhythmogenesis has a multifactorial nature and the occurrence of malignant arrhythmias in subjects with cardiac electrical instability is unpredictable, all anatomically documented MI as well as all ventricular arrhythmic events (VAEs) were included in the study independently of their size and complexity, respectively.
Animal Instrumentation for Telemetry-ECG Recording
Anaesthetized animals ( Fig. 2) were chronically instrumented with a miniaturized transmitter for telemetry-ECG recording (model TA11CTA-F40; Data Sciences, St. Paul, MN). The details of the surgical procedure have been published (71) . VAEs (n)
Post-inj. Pre-inj. number of stress-induced ventricular arrhythmic events (VAEs) in SO-vehicle (SO-V) (n ϭ 6), SO-growth factor (SO-GF) (n ϭ 4), SO-cardiac progenitor cells (SO-CPC) (n ϭ 7), and SO-CPC ϩ GF (n ϭ 7) groups, before and after injection (Pre-inj. and Post-inj., respectively). In the various plots, continuous lines correspond to individual animals; dashed lines indicate the average behavior within the corresponding group. Data in bar graphs (B-E) illustrate the means Ϯ SE of hemodynamic parameters measured before death in the 4 groups of animals: left ventricular systolic pressure (LVSP; B), LV end-diastolic pressure (LVEDP; C), maximum rate of ventricular pressure rise (ϩdP/dt; D) and reduction (ϪdP/dt; E). Functional parameters exhibited comparable values in all experimental groups, independently of the treatment.
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Social Stress Procedure and Telemetry-ECG Data Acquisition and Processing
Social stress was obtained by the resident-intruder test paradigm (43) , which consists of introducing the instrumented animal (intruder) into the territory of an unfamiliar conspecific male (resident).
All experimental sessions were performed during the light phase, between 9.00 AM and 1.00 PM, and each session was made up of two successive 15-min continuous telemetry-ECG recordings while the instrumented animal was respectively 1) left alone and undisturbed in its home cage (baseline conditions), and 2) exposed to the social stress procedure (test period). The ECG signals were collected with a receiver (model CTR85-SA; Data Sciences) placed under the experimental cage and subsequently processed as previously described (6), using a customized software package for interactive analysis of heart rate and heart rate variability and detection of VAEs. Two time domain indexes of heart rate variability were computed as indirect measurements of the autonomic input to the heart during baseline or stress exposure, including: 1) the standard deviation of the mean R-R interval duration (SDRR), which quantifies the balance between sympathetic and parasympathetic activities on the heart, and 2) the root mean square of successive R-R interval square differences (r-MSSD), which reflects high-frequency, short-term variations of R-R interval, predominantly attributable to parasympathetic influences (76) . VAEs were classified according to the Lambeth Conventions (88) .
MI and SO
Anesthetized rats (Fig. 2) were intubated with a suitably modified 16-gauge needle and artificially ventilated (Rodent ventilator UB 7025; Ugo Basile, Comerio, Italy). Subsequently, a thoracotomy was performed via the third left intercostal space, and a 5-0 silk suture was passed with a tapered needle under the left anterior descending coronary artery 2-3 mm from the tip of the left auricle and tied securely, as earlier published (6) . The chest was then closed in layers, and a small catheter was introduced in the thorax to evacuate air and fluids. Eventually, the rats were removed from the ventilator and cured for postoperative healing (6) . SO animals were treated similarly, except that the ligature around the coronary artery was not tied.
CPC Isolation and Amplification
CPCs were isolated from the whole heart of 3-mo-old male Wistar rats, via a methodology well established in our laboratory (24 -25) and in accordance with the procedure described by Beltrami et al. (5) , with minor modifications. For cell-tracking experiments, GFP pos CPCs were obtained through the same procedure from transgenic GFP pos rats of similar age, originally generated in Dr. M. Okabe's laboratory (53) . Briefly, the excised heart was enzymatically digested by perfusion with collagenase type II solution (0.5 mg/ml, 285 U/mg; Worthington Biochemical, Lakewood, NJ), and, after removal of cardiomyocytes, cells were layered on Percoll (Sigma, Milan, Italy) gradient for further enrichment. The cell layer visualized at the interface of the desired gradient was resuspended in 10 ml of Iscove Modified Dulbecco's Medium (IMDM) supplemented with 1% penicillin-streptomycin (Pen Strep), 1% insulin-transferrin-sodium selenite, 10% FBS, and 10 ng/ml basic fibroblast growth factor (all from Sigma) and seeded on Petri dishes (Sigma) for their amplification. As repeatedly documented, these cells largely express c-kit, the receptor for stem cell factor (Fig. 3) , are self-renewing, clonogenic, and multipotent, possessing the fundamental properties that define CPCs (4 -5). In our typical preparations, c-kit was expressed in 87.2 Ϯ 5.4% of isolated CPCs (polyclonal rabbit antibody; Santa Cruz Biotechnology, Dallas, TX; see Table 1 ). Aliquots were cryopreserved in a medium supplemented with 1% DMSO (Sigma).
Intramyocardial Injection of CPCs
Four weeks after coronary ligature, left lateral thoracotomy was repeated in all animals under anesthesia and mechanical ventilation, as described above. Afterward, selected subgroups of animals were treated with 6 ϫ 10 5 syngeneic wild-type CPCs or GFP pos CPCs (Fig.  2) , suspended in 300 l of IMDM supplemented with 1% Pen Strep. CPCs or GFP pos CPCs were delivered in four equally spaced myocardial regions bordering the scar, either alone (MI-CPC hearts) or in combination with HGF (200 ng/ml; PeproTech EC, London, United Kingdom) plus IGF-1 (200 ng/ml; PeproTech EC) (MI-CPC ϩ GF hearts). MI-GF animals were given GFs only. The volume of each injection was 100 l. Untreated MI animals (MI-V group) received equal volumes of saline, by the same procedure.
BrdC Administration
In MI animals randomly selected for BrdC administration (Fig. 2) , along with surgery for local injection of GFs, CPCs, CPCs ϩ GFs, or V, an osmotic pump (model 2ML4; ALZET; Charles River Laboratories Italia, Calco, Italy) was implanted subcutaneously in the interscapular region to enable a continuous infusion of BrdC 0.6 mol/l (MP Biomedicals Europe, Illkirch, France) at a delivery rate of 2.5 l/h. Infusion was maintained until the animals were killed (2 wk). This long infusion time prompted us to use BrdC in place of the most commonly employed BrdU, owing to the almost sixfold higher solubility of BrdC (which in vivo is metabolically converted to BrdU, as mentioned above).
Hemodynamic Study
Animals (Fig. 2) were anesthetized with droperidol ϩ fentanyl citrate 1.5 mg/kg im (Leptofen; PHARMACIA & UPJOHN, Milan, Italy), which, in our experience, exerts negligible effects on hemodynamic parameters.
The right carotid artery was cannulated with a microtip pressure transducer catheter (Millar SPC-320; Millar Instruments, Houston, TX) connected to a recording system (Power Laboratory ML 845/4 channels; 2Biological Instruments, Besozzo, Italy), and both systolic and diastolic blood pressures were determined. The catheter was then advanced into the LV to measure: 1) LV systolic pressure (LVSP); 2) LV end-diastolic pressure (LVEDP); 3) maximum rate of ventricular pressure rise (ϩdP/dt) and reduction (ϪdP/dt), taken as indexes of ventricular mechanical efficiency; 4) isovolumic contraction time (IVCT, duration of isovolumic contraction, computed from LVEDP to the time of aortic valve opening); 5) LV relaxation time (IVRT, duration of isovolumic relaxation, computed from ϪdP/dt to 5 mmHg above LVEDP), and 6) ejection time (ET, approximated as the time interval between aortic valve opening and time of ϪdP/dt) (software package AcqKnowledge 3.9; Biopac Systems, Goleta, CA). Eventually, we computed the myocardial performance index (MPI) as the ratio of total time spent in isovolumic activity (IVCT ϩ IVRT) to ET: (IVCT ϩ IVRT)/ET (66) . MPI is considered to reflect global cardiac function and possess prognostic value after MI (47). 
Epicardial Multiple-Lead Recording
Animals under anesthesia and artificially ventilated (Fig. 2) were subjected to left thoracotomy. Body temperature was held constant at 37°C by infrared lamp radiation. Sixty-four unipolar EGs were simultaneously recorded from the epicardial surface via an 8 ϫ 8 row and column electrode array with 1-mm interelectrode distance. The array was positioned over the infarcted region and the surrounding areas, just below the site of coronary ligature. The details of the surgical approach, the construction of the multiple electrode grid, and the recording system have already been described (40) . EG recordings were performed during normal sinus rhythm or pacing by specific protocols at 4 -18 selected electrodes of the array (Fig. 4A ), using near-threshold, Յ1-ms cathodal current pulses, at a frequency as specified when appropriate. During pacing, EGs were obtained from all the electrodes except at the paced site (Fig. 4B ). As indicated earlier (6), in some cases, the proper positioning of the array on the ventricular epicardium was prevented by an unfavorable spatial relationship between heart and lungs in the open chest preparation. Because of this and the presence of scattered fibrotic areas in the infarcted region, only a fraction of the 64 sites explored by epicardial electrodes was excitable and/or enabled the recording of reliable EG signals. The measurements were carried out in accordance with standard procedures (35, 40, 52) and included conduction velocity (CV), excitability, refractoriness, dispersion of refractoriness, and quantification of spatial inhomogeneity in conduction.
Conduction velocity. Activation time at each electrode site was estimated using the instant of the minimum time derivative of unipolar EG during QRS and was referenced to stimulus onset of paced beats at a frequency slightly higher than spontaneous sinus rhythm (basic cycle length, BCL Ϸ300 ms). From the activation times, an activation sequence (isochrone map) was determined where CV was computed longitudinally (CV-l) and transversally (CV-t) to epicardial fiber orientation ( Fig. 4C) , as previously detailed (6, 79) .
Excitability. Four to eight selected electrodes of the array (Fig. 4A ) were initially paced at BCL with current pulses of decreasing strength (starting from supraliminal values) at a constant duration of 5 ms until activation failed, thus identifying the threshold current. The procedure was then repeated with current pulses of progressively shorter duration, down to 0.01 ms. The threshold currents as a function of pulse duration defined the strength-duration (S-D) curve from which the related parameters Rheobase (Rh) and Chronaxie (Chr) were obtained, univocally identifying the S-D curve and thus characterizing tissue excitability (6, 10) (Fig. 4D) .
Refractoriness. At each of the 4 -18 selected electrodes of the array (Fig. 4A ), eight BCL stimuli (S1), 1-ms duration and twice diastolic threshold current strength, were delivered. The S1 pacing sequence was followed by an extra stimulus (S2) whose delay from previous S1 was first progressively decremented by 10-ms steps until capture was lost and then progressively incremented by 2-ms steps until capture was resumed. The longest S1-S2 coupling interval that did not originate ventricular capture identified the effective refractory period (ERP) at a given electrode site, enabling the characterization of spatial differences in tissue refractoriness.
Dispersion of refractoriness. The degree of dispersion was evaluated by computing the ERP dispersion value taken as a basic indicator of propensity to reentrant arrhythmias (54) and, in an individual animal, was expressed by the standard deviation of the mean ERP at all test sites (52) .
Quantification of spatial inhomogeneity in conduction. Given the recognized significance of spatial inhomogeneities in propagation for strength-duration curve obtained in a control rat by plotting pulse threshold current I as a function of pulse duration T. Rh is the Rheobase, i.e., the lowest current strength with infinite pulse duration, which succeeds in eliciting a propagated response in excitable tissues. Chr is the Chronaxie, i.e., the pulse duration having a threshold current strength twice that of Rh. the initiation of reentrant arrhythmias, maps of spatial distribution of inhomogeneities in conduction (phase maps) were obtained from isochrone maps, in accordance with Lammers et al. (35) . Briefly, the local phase differences in activation times were calculated for each quadruplet of neighboring recording points. The total population of phase differences were then plotted as a histogram and described by percentile scores. The total range in maximal differences in activation times (P 5-95) was used to express the absolute inhomogeneity in conduction. The variant coefficient (P5-95/P50) was used as an inhomogeneity index to express the local inhomogeneity independent of conduction velocity. In each animal, four phase maps were obtained by impulse delivered at as many stimulating points, at BCL driving frequency.
Cardiac Anatomy
The heart of anesthetized animals ( Fig. 2 ) was arrested in diastole by injection of 5 ml of cadmium chloride (100 mmol/l iv) and briefly perfused at physiological mean arterial blood pressure with heparinized PBS, followed by 10-min perfusion with 10% of formalin solution. The heart was excised and fixed for 24 h in 10% formalin, and the right ventricle and the LV, including the septum, were separately weighed. The volume of the LV myocardium was computed by dividing the ventricular weight by the specific gravity of the tissue (1.06 g/ml). The major cavitary axis of the LV was measured from the aortic valve to the apex under a stereomicroscope with a ruler calibrated exactly to 0.1 m (2Biological Instruments). Subsequently, the LV was sliced in three transverse sections corresponding respectively to the base, equatorial portion, and apex. On the equatorial section, LV wall thickness and LV chamber diameter were measured using software for image analysis (Image Pro-plus, version 7.0; Media Cybernetics, Rockville, MD). LV chamber volume was calculated according to the Dodge equation, which equalizes the ventricular cavity to an ellipsoid (19) . Finally, the basal, equatorial, and apical sections were embedded in paraffin, and 5-m-thick slices were cut for morphometric and immunohistochemical studies.
Morphometric Analysis
In rat hearts from the different groups ( Fig. 2) , infarct size was morphometrically evaluated according to a methodology repeatedly employed in our laboratory (6) . Briefly, hematoxylin and eosinstained sections were analyzed, and the quotient between the number of myocytes present in the infarcted portion of LV and the number of LV myocytes in the corresponding portion of SO hearts represented the quantitative measurement of infarct size. The newly formed myocardium in treated hearts was not included in this analysis so as to ascertain the consequences of coronary ligation on infarct size, independently of tissue reconstitution.
In the same animals, 5-m-thick slices from the LV equatorial section stained with Masson's trichrome were analyzed via optical microscopy (magnification ϫ250) to evaluate in the remote and peri-infarcted spared myocardium, namely 1) the volume fraction of myocytes and 2) the volume fraction of diffuse and replacement fibrosis. As previously reported (77), on each slice, this analysis was performed in 60 adjacent fields from subendocardium to subepicardium, with the aid of a grid defining a tissue area of 0.160 mm 2 and containing 42 sampling points. The number of points overlying cardiomyocytes and fibrotic tissue was counted and expressed as a percentage of the total number of points explored.
Finally, the cross-sectional area of cardiomyocytes in the spared myocardium was morphometrically determined by measuring the cell diameter at the level of the nucleus, in transversally oriented cells. On each heart, 120 -250 individual measurements were performed.
Immunohistochemistry
Six randomly selected MI-V and MI-GF rat hearts and as many MI-CPC and MI-CPC ϩ GF, among those injected with GFP pos CPCs, were subjected to immunohistochemical studies (Fig. 2) . Fivemicrometer-thick LV sections were analyzed by confocal microscopy (Zeiss 510 meta confocal microscope) to determine 1) the number of engrafted GFP pos CPCs and their differentiation into cardiac lineages, 2) the fraction of BrdU-labeled nuclei in the infarcted ϩ peri-infarcted LV myocardium, and 3) the expression and spatial distribution of Cx43 and Cx40. GFP, ␣-sarcomeric actin (␣-SA), ␣-smooth muscle actin (␣-SMA), von Willebrand factor, CD31/platelet endothelial cell adhesion molecule-1 (CD31/PECAM-1), Ki-67, connexins, and BrdU were detected via specific antibodies and immunofluorescence. For this purpose, LV sections were incubated with the primary antibody ( Table 1) followed by exposure to FITC-, tetramethylrhodamine isothiocyanate-, or Cyanine5-conjugated donkey secondary antibodies (Jackson Laboratory, Bar Harbor, ME) to simultaneously detect different epitopes. To ascertain the expression of GFP and to avoid cross reactivity when multiple epitopes were to be investigated, two different GFP primary antibodies were employed, as appropriate (Table 1) . Nuclei were stained by DAPI (Sigma). A cover slip was mounted with Vectashield (Vector Laboratories, Burlingame, CA) on each slide for fluorescence microscopy.
The quantitative measurement of Cx43 and Cx40 immunofluorescent signals was performed in the zone bordering the infarct. After immunostaining, microscopic images were recorded with identical acquisition parameters in areas of comparable size and orientation of cardiomyocytes. As fibroblasts from the infarcted areas are known to express connexins (12) , to achieve reliable information on connexin density in the myocyte compartment, the zones occupied by interstitial fibroblasts and coronary vasculature were excluded from the analysis by morphology. Sampling involved a minimum of 0.75 mm 2 to a maximum of 1.2 mm 2 of myocardium for each connexin immunolabeling, in each experimental group. The area and the intensity of fluorescence of each spot were measured with the Image Pro-plus software. On the basis of the notion that intensity and size of individual areas occupied by fluorescence signals distribute over a rather wide value interval, we applied a corrected quantification approach by computing the data of fluorescence intensity, spot dimension, and number of spots relative to the myocardial tissue unit area.
CPC engraftment and differentiation were determined by analyzing a minimum of 1.12 mm 2 up to a maximum of 3.89 mm 2 of myocardium on each GFP pos CPC-injected rat heart. An overall area of 63.39 mm 2 and 61.93 mm 2 of myocardium was analyzed in MI-CPC and MI-CPC ϩ GF rats, respectively. The amount of newly formed myocardium was computed by calculating the number of small GFP pos /␣-SA pos myocytes following a previously described methodology (6) .
Finally, the density of resistance arterioles and capillary (n/mm 2 ) in surviving myocardium was measured by counting respectively vascular and microvascular profiles labeled by anti-␣-SMA and CD31/ PECAM-1 antibodies.
mRNA Expression of Connexins, Ion Channels, and Adrenergic Receptors by qRT-PCR.
We assessed the mRNA expression level of major connexins in the conductive and working myocardium (Cx43, Cx40, and Cx45) as well as the channel proteins of 1) depolarizing ion currents: INa (Nav1.5), ICa,L (Cav1.2), and ICa,T (Cav3.1) and 2) repolarizing ion currents: Ito (Kv4.2, Kv4.3, Kv1.4), IKr (Kv11.1), IKs (Kv7.1), and IK1 (Kir2.1, Kir2.2). Transcripts of adrenergic ␤1-and ␤2-receptors were also determined. The analysis was performed on the infarcted ϩ periinfarcted myocardium of 4 SO-T, 2 MI-GF, 2 MI-V, 4 MI-CPC, and 4 MI-CPC ϩ GF animals, in technical triplicate for each heart (Fig. 2) . Briefly, after homogenization of the tissues, total RNA was extracted using TRIzol reagent (Invitrogen, Life Technologies, Monza, Italy) according to the manufacturer's recommendations. The quantity and the quality of total RNA were assessed by absorbance 260 nm and 280 nm and by gel electrophoresis. One microgram of total RNA was reverse transcribed using high-capacity cDNA reverse transcription kit (Applied Biosystems Italia, Monza, Italy). Reverse transcription was performed at 25°C for 10 min, 37°C for 120 min, and stopped by incubating at 85°C for 5 s. Gene expression was assessed by real-time qPCR (7900HT, Applied Biosystems) using GoTaq qPCR master mix syber green (Promega Italia, Milan, Italy) and specific primers ( Table  2 ). Primers and probes were obtained from Applied Biosystems and Sigma. Expression values were presented using the ⌬CT and normalized to the housekeeping gene (cyclophilin, kindly provided by Dr. Quintavalle, Humanitas Research Center, Rozzano, Italy). Results are reported as means Ϯ SE of -⌬CT values.
Electrophoretic and immunoblot analysis.
The infarcted ϩ peri-infarcted portions of the LVs obtained from 2 SO-T, 2 MI-V, 2 MI-GF, 3 MI-CPC, and 4 MI-CPC ϩ GF animals ( Fig. 2) were immediately frozen at Ϫ80°C. For immunoblot assay of Cx43 and Cx40, the fresh ventricular tissue was mechanically fragmented in liquid nitrogen and lysed with 300 l of lysis buffer containing the following (all from Sigma): protease (1:100) and phosphatase (1:100) inhibitors, NaCl (150 mmol), Tris·HCl (50 mmol), EDTA (5 mmol), Nonidet P-40 (1%), sodium fluoride solution (10 mmol), sodium diphosphate dibasic (10 mmol), SDS (0.1%), and sodium deoxycholate (0.5%). For each animal, equivalents of 50 g of protein were separated by 10.5% SDS-PAGE. Coomassie blue dye was used for staining proteins in SDS-PAGE gels and to check the quality of each sample. After electrophoresis, the proteins were transferred onto nitrocellulose membranes to perform the antibody detection. Membranes were blocked with 5% milk in Tris-buffered saline with Tween-20 (Sigma) and incubated overnight at 4°C with the primary polyclonal rabbit anti-Cx43 antibody (1:8,000; Abcam, Cambridge, MA), or the primary polyclonal rabbit anti-Cx40 antibody (1:2,000, Abcam). The second incubation was performed for 1 h at room temperature with peroxidase-conjugated affinity-purified goat anti-rabbit secondary antibody (Bio-Rad Laboratories, Hercules, CA). Peroxidase activity was developed using the enhanced chemiluminescence Western blotting system (Amersham Rahn, Zürich, Switzerland), according to the manufacturer's instructions. To determine the expression levels of Cx43 and Cx40, blots were scanned, and the intensity of the band was quantified by means of the ImageJ Program (NIH, Bethesda, MD). All measurements were performed in technical triplicate. Actin was used as the loading control (primary polyclonal rabbit anti-actin antibody, 1:5,000; Sigma). More than one gel was used for determining the average value of each protein because our set-up for Western blot assay allows running only eight samples simultaneously. Thus to obtain measurements in triplicate for every connexin protein in each sample (2 SO-T, 2 MI-V, 2 MI-GF, 3 MI-CPC, and 4 MI-CPC ϩ GF), we ran the samples together with the internal control (actin) five times. For each run, the 2 SO-T samples were always present.
Statistical Analysis
The SPSS statistical package was used (version 18; SPSS, Chicago, IL). 
RESULTS
Telemetry-ECG Data: Proneness to Arrhythmias in Conscious, Freely Moving MI Rats Was Lowered by GFs and Even More GF-Implemented CPCs
Arrhythmia vulnerability was evaluated as the number of VAEs during 15-min baseline and stress-induced sympathetic stimulation periods. In the various trials, VAEs were represented by isolated premature beats, some couplets, and, in several instances, more complex patterns, mainly found in rats with MI (Fig. 5A ). Before injection of GFs, CPCs, CPCs ϩ GFs, or V, a few VAEs occurred in MI rats during baseline (average number: 4.5 Ϯ 1.6), whereas stress VAEs were documented in both SO and MI animals, but at a higher level in the latter group (3.2 Ϯ 0.3 vs. 9.9 Ϯ 0.2; P Ͻ 0.01). After injection, stress VAEs did not vary significantly in SO-T and MI-V and MI-CPC rats compared with preinjection values (Fig. 5, B, C, and E) . In contrast, the coinjection of CPCs and GFs significantly reduced stress VAEs by about half (P Ͻ 0.02 vs. preinjection values, Fig. 5F ) in all animals. GFs alone too succeeded in diminishing stress VAEs (P Ͻ 0.05 vs. preinjection values; Fig. 5D ) yet in a lower percentage of animals (67 vs. 100%, P Ͻ 0.05, 2 test, Fig. 5D ). By these data, GF adjunct appeared to exert a pivotal role in restoring ventricular electrical stability in CPC-mediated repair of chronic MI, whereas GFs alone had smaller beneficial effects.
Furthermore, telemetry-ECGs were subjected to time-domain analysis of heart rate variability (75) to assess whether the reduced arrhythmic risk in MI-CPC ϩ GF and MI-GF animals was related to changes in cardiac autonomic input, which were 
reported to be involved in arrhythmias following regenerative therapies (56, 92) . During baseline, the indexes of heart rate variability SDRR and r-MSSD were similar in the different groups (Table 3) , before and after injection. The rise in sympathetic tone brought about by the social challenge (70) reduced SDRR and r-MSSD by nearly 45 and 30%, respectively (P Ͻ 0.05) in the various animals, with no difference before and after treatment. Likewise, R-R interval during both baseline and stress conditions did not differ in the five rat groups (Table 3) . Finally, in accordance with previous studies (8, 9, 28) , LV ␤-receptor transcript levels either were not affected by MI (BETA-2) or were reduced (BETA-1). In the latter case, the decline was evenly restored by GF, CPC, and CPC ϩ GF treatments (Fig. 6) . Thus direct and indirect markers of the autonomic input to the heart had comparable values in the three cured MI groups.
Epicardial Multiple-Lead Recordings: Negative Remodeling of Basic Cardiac Electrophysiological Properties After MI Was Restored in a Different Way by Regenerative Treatments
The electrophysiological mechanisms underlying the antiarrhythmic effects of CPCs ϩ GFs compared with sole CPCs or GFs were explored at tissue level by epicardial measurements
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Pre-inj. Post-inj. of basic cardiac electrophysiological properties, namely CV, excitability, and refractoriness, as well as spatial dispersion of refractoriness. Epicardial recordings were further examined by phase maps (35) to evaluate the spatial distribution of inhomogeneity in conduction, which offers the possibility to detect areas of initial conduction block and correlates with the induction of reentrant arrhythmias.
CV-l was faster in MI-V group than SO-T, whereas CV-t was slower (ϩ9% and Ϫ13%, respectively; P Ͻ 0.05) (Fig. 7,  A and B) . These changes were reversed by both CPC and CPC ϩ GF administration (P Ͻ 0.05) with slightly larger effects of CPC ϩ GF on CV-l (Fig. 7, A and B) . Concomitantly, the high values of CV-l/CV-t anisotropy ratio in MI-V rats (ϩ20% vs. SO-T), fell by about 15% in MI-CPC and matched SO-T values in MI-CPC ϩ GF (Fig. 7C) . Quite the opposite, MI-GF rats behaved similarly to MI-V, without any apparent effect of the treatment on in CV-l and CV-t alterations and, consequently, cardiac anisotropy, brought about by the ischemic injury. Of note, even small variations in propagation velocity are functionally important, as they reflect significant changes in cell-to-cell coupling attributable to the massive redundancy of gap junction-mediated intercellular communications (86) .
In phase-mapping studies, the absolute inhomogeneity in conduction, described by percentile scores and expressed as P (35) , did not show any difference among groups at BCL (Ϸ300 ms) (Fig. 7D) . In contrast, the inhomogeneity independent of the average conduction velocity (P 5-95 /P 50 ) was similarly increased in all treated and untreated MI animals (about 2-fold) compared with SO-T (Fig. 7E) , suggesting that the observed CV-l slowing against MI-V caused by CPCs and even more by CPCs ϩ GFs (Fig. 7A) was not attributable to changes in local inhomogeneity.
Myocardial excitability was assessed by means of S-D curves and the related Rh and Chr values (see Fig. 4D ). Roughly, Rh and Chr were respectively 20-fold and 2-fold greater in MI-V animals than SO-T (Fig. 7 , F and G; P Ͻ 0.01), leading to a shift upward and to the right of S-D curves and hence a decline in cardiac excitability properties. In general, these changes were partially reverted by both CPCs and CPCs ϩ GFs, whereas they were not affected by GFs alone, with the concomitant persistence of a high excitation threshold in MI-GF group.
The ERP trended to be slightly prolonged, and its dispersion was significantly increased by coronary ligature compared with SO-T (Fig. 7 , H and I; P Ͻ 0.01). CPC and CPC ϩ GF administration induced an additional ERP lengthening while reducing ERP dispersion, with comparable effects in the two animal groups (Fig. 7, H and I) . GFs alone pushed ERP duration further up without any beneficial consequence on dispersion (Fig. 7, H and I) .
Overall, data on basic cardiac electrophysiological properties indicated that CPCs and more so CPCs ϩ GFs restored toward control values ventricular CV-l/CV-t anisotropy ratio enhanced by infarction, whereas the consequences of both treatments on cardiac excitability (partial recovery) and refractoriness (prolongation) were nearly alike. GFs alone increased ERP duration compared with MI-V as well as CPC and CPC ϩ GF, without any significant impact on excitability and CV parameters. Values are means Ϯ SE of: 1) R-R interval, 2) the SD of the mean R-R interval duration (SDRR), and 3) the root mean square of successive R-R interval square differences (r-MSSD), measured by telemetry ECG, before (Preinjection) and 15 days after treatment (Postinjection), in the different experimental groups. *P Ͻ 0.05 significant differences vs. baseline values, within each group. SO, sham operation; MI, myocardial infarction; T, treatment; V, vehicle; GF, growth factor; CPC, cardiac progenitor cell. Average values Ϯ SE of -⌬Ct, compared with cyclophyllin, of mRNA levels for ␤1-(BETA-1) and ␤2-(BE-TA-2) adrenergic receptor isoforms, measured in the infarcted ϩ peri-infarcted ventricular myocardium of MI-V (n ϭ 2), MI-GF (n ϭ 2), MI-CPC (n ϭ 4), and MI-CPC ϩ GF rats (n ϭ 4), against SO-T (n ϭ 4). Each bar represents the mean of the different samples, in technical triplicate. *P Ͻ 0.05 vs. SO-T.
Table 3. R-R interval and R-R variability indexes
Different Effects of Regenerative Treatments on Cellular and Molecular Determinants of Basic Cardiac Electrophysiological Properties and Vulnerability to Arrhythmias
It is generally recognized that local safe propagation of the impulse in cardiac tissue results from an optimal match between several variables, which also govern basic cardiac electrophysiological properties, such as cell-to-cell coupling, expression of ion channels, microscopic tissue structure, and cell morphology (31) .
Gene expression analyses of cardiac connexins and ion channel subunits. In the infarcted ϩ peri-infarcted area of untreated MI rat hearts, mRNA expression levels of Cx43 and channel proteins of the depolarizing ion currents I Na (Na v 1. K ir 2.2) were markedly reduced compared with sham animals (range: Ϫ20/Ϫ170%; P Ͻ 0.05; Fig. 8, A-E) . On the contrary, Cx45 and Cx40 isoforms and channel subunit Ca v 3.1 were not affected by the ischemic damage, exhibiting equivalent values in SO-T and MI-V groups (Fig. 8, A and B all transcripts except K v 4.3, whereas CPCs with GF adjunct had a more limited/specific action, suggesting that the two treatments differently cured the expression of transcripts deteriorated by the ischemic damage (Fig. 8, A-D) . Importantly, as Cx45, Ca v 3.1, and K v 1.4 transcripts are mainly expressed in early stages of cardiac development, an increase during regenerative processes might be anticipated (1, 16, 85) . Indeed, this was the case for K v 1.4, whereas Cx45 and Ca v 3.1 did not exhibit any sizeable difference among groups. However, in our experimental conditions, we could not exclude a possible masking effect on the two latter transcripts attributable to the overwhelming number of spare, mature myocytes in the infarcted area, opposite to newly formed myocytes.
Expression of Cx43 and Cx40 at protein level. It is known that during MI healing and scar formation, most action potentials of surviving myocytes in the border zone revert toward normal, highlighting the role of connexins as determinants of slow conduction and conduction block, necessary for reentrymediated arrhythmias (91) . Therefore, we further explored the expression of connexin isoforms, Cx43 and Cx40, in working myocytes of the adult heart at the protein level. Immunoblot assay documented that Cx40 and Cx43 expression in MI-V animals was approximately halved against SO-T (Fig. 9 , A and B; P Ͻ 0.01). GF treatment with or without CPCs brought back toward control values the expression levels of both connexins, curing the negative impact of MI (P Ͻ 0.05), whereas CPCs alone did not (Fig. 9, A and B) . Importantly, Cx43 expression roughly exhibited a similar behavior at mRNA and protein levels in the four MI experimental groups. On the contrary, the differences in Cx40 expression, which were unable to attain any statistical significance among groups by qRT-PCR, became clearly patent in immunoblot studies, suggesting a translational control of the corresponding gene. The above results were confirmed by immunofluorescence analysis, which generally documented similar trends of Cx40 and Cx43 changes in the various MI groups (Figs. 10 and 11 ), compared with Western blot ones, although the quantitative values and hence statistical significance in the two sets of data were only partly overlapping. This, however, was not surprising because of the methodological differences in immunoblot and immunofluorescence approaches.
Structural arrhythmogenic substrate: myocardial fibrosis and cell size. The amount of collagen accumulation, mostly in the form of diffuse interstitial and focal fibrosis, was barely detectable in SO-T animals and reached a value of about 2% of the remote myocardium in both treated and untreated MI hearts (MI-V: 1.82 Ϯ 0.8; MI-GF: 1.32 Ϯ 0.2; MI-CPC: 1.65 Ϯ 0.1; MI-CPC ϩ GF: 1.74 Ϯ 0.1). In contrast, in the peri-infarcted myocardium, the three regenerative therapies reduced fibrotic damage by about 50% compared with MI-V ( Fig. 12 ; P Ͻ 0.01). Finally, no significant differences were found among treated and untreated MI rat hearts in the hypertrophic response of spared cardiomyocytes, as measured by cross-sectional area (SO-T: 291.7 Ϯ 17.4 m 2 ; MI-V: 475.6 Ϯ 15.3; MI-GF: 392.4 Ϯ 19.3; MI-CPC: 441.9 Ϯ 11.4; and MI-CPC ϩ GF: 486.9 Ϯ 18.2). As a result, myocardial fibrosis and cell size, which can modulate the impulse propagation in the heart with a major impact on its electrical stability, were similarly affected in all treated groups.
The finding that CPCs with or without GF adjunct and GFs alone have different consequences on cardiac electrical competence prompted us to extend our observations to cardiac mechanics, anatomy, and regeneration.
Restoration of Cardiac Mechanical Function and Anatomy Was Equivalent in All Treated MI
LV mechanics. Marked signs of systolic and diastolic ventricular dysfunction developed in untreated MI-V animals against SO-T, including a significant increase in LVEDP (ϩ50%; P Ͻ 0.05), a reduction in ϩdP/dt and ϪdP/dt, a prolongation of IVCT and IVRT, and an increase in the MPI (Table 4 ). In contrast, the ET showed comparable values among groups. Of note, the impairment of ϩdP/dt and LVEDP in MI-V rats was significantly correlated with postmortem determination of infarct size (Fig. 13, A and B) .
As a rule, the three regenerative treatments improved cardiac performance in a similar fashion, with a significant recovery of most hemodynamic parameters compared with MI-V (Table  4) . Additionally, the correlations among deteriorated parameters and infarct size disappeared in MI-GF, MI-CPC, and MI-CPC ϩ GF animals (Fig. 14, A-F) , supporting the hypothesis that all regenerative therapies induced a parallel, partial recovery of ventricular mechanical performance, thus making cardiac function independent of the amount of tissue lost.
Cardiac anatomy. MI-V animals exhibited a significant dilation of LV chamber associated with a marked reduction in mass-to-chamber volume ratio (Fig. 15, A and B) . The unfavorable anatomical remodeling following MI was reversed by GF, CPC, and CPC ϩ GF administration in a similar fashion (Fig. 15, A and B) . Concomitantly, all treatments had comparable effects on collagen deposition and cell size, as described above. Hence, by structural and anatomical data, the favorable effects of GFs, CPCs and CPCs ϩ GFs on cardiac remodeling of the infarcted heart were equivalent.
Differential Influence of Treatments on Myocardial Repair
Engraftment of CPCs and formation of new functionally competent myocardium in MI-CPC and MI-CPC ϩ GF hearts were documented by the presence of small, GFP pos /␣-SA pos cardiomyocytes expressing Cx43 and Cx40 gap junctional proteins (Fig. 16, A and B) . Quantification of these regenerative processes showed that, in the infarcted area, the density of GFP pos cardiomyocytes was twofold higher in MI-CPC ϩ GF than MI-CPC ( Fig. 16; bar graph) .
The effects of the injection of GFs, CPCs, or CPCs ϩ GFs on cell proliferation were determined by analyzing BrdU incorporation in myocardial cells. All treatments had a positive impact on cardiomyocyte proliferation in the infarcted myocardium (Fig. 17, A-D ). An increase up to 10-fold (P Ͻ 0.05) in DNA replication was measured in MI-GF, MI-CPC, and MI-CPC ϩ GF rat hearts compared with untreated ones ( Fig.  17; bar graph) . Importantly, an additional marker of cycling cardiomyocytes, Ki-67, was simultaneously detected with BrdU labeling (Fig. 17, E-G) .
Vasculogenesis in the infarcted area of treated animals was demonstrated by the presence of GFP pos arterioles, attributable to CPC differentiation into ␣-SMA pos cells, as well as GFP pos capillary profiles (Fig. 18, A-D) . To assess the differential impact of the three regenerative approaches on the recovery of myocardial perfusion, the cumulative arteriolar density was determined, indicating a significant comparable improvement in all treated animals against MI-V ( Fig. 18; bar graph) . Similarly, the rarefaction of CD31/PECAM-1-labeled capillaries brought about by MI in the surviving myocardium (MI-V: 1,110 Ϯ 103 n/mm 2 ) was equally restored by all three repairing treatments (MI-GF: 1,527 Ϯ 109 n/mm 2 ; MI-CPC 1,305 Ϯ 155; MI-CPC ϩ GF 1,546 Ϯ 244).
DISCUSSION
The present study demonstrates that, in the setting of chronic MI, local injection of CPCs with the addition of GFs is antiarrhythmic, largely restoring cardiac electrical viability altered by ischemic injury, whereas CPCs alone do not have comparable, beneficial electrophysiological consequences. The ability of CPCs ϩ GFs to ameliorate the electrogenesis of the mended heart was at least partly attributable to the recovery toward control values of cardiac anisotropy ratio CV-l/CV-t. This in turn was likely consequent to a parallel recovery of the expression levels of Cx43 and Cx40 isoforms as well as ion channel subunit Ca v 1.2, favorably affecting cardiomyocyte coupling and the spread of ventricular excitation. The injection of individual GFs reduced arrhythmias by less than CPCs ϩ GFs. The better electrical function in MI-GF rats against untreated MI appeared to result from a prolongation of ventricular refractoriness and was associated with a generalized recovery of most gap junctional and ionic channel proteins. GF administration with or without CPCs resulted in an increased capacity of injected/resident CPCs to generate functionally competent myocardium within the infarct. The more robust repopulation of the damaged heart by newly formed appropriately connected myocytes might also have contributed to attenuation of cardiac electrical instability.
Decreased Proneness to Stress-Induced Arrhythmias and Autonomic Control
GF administration and still further CPC ϩ GF significantly decreased the number of ventricular arrhythmias triggered by stress-mediated sympathetic stimulation, in conscious, freely moving animals. The duration of the recording epoch (a single 15-min recording), which may appear as a relatively short time window for appreciating baseline arrhythmic propensity, is a rather validated methodology in the literature to establish stress-induced vulnerability to cardiac arrhythmic episodes within a given phase of the light/dark rhythm (70) . Additionally, the enhanced sympathetic activity related to stress mimics circumstances encountered by social animals in everyday life, implying that our approach to induce arrhythmias by targeting the autonomic nervous system provides a more faithful representation of human clinical conditions (70) . Published data (56) have indicated that mesenchymal stem cell therapy in a swine model of MI can increase sympathetic nerve sprouting, with a potential arrhythmogenic effect. By contrast, in the same animal model, induced pluripotent stem cell transplantation ameliorated neural remodeling and reduced ventricular arrhythmias (92) . In the present study, no significant difference in heart rate variability indexes was apparent among MI-GF, MI-CPC, and MI-CPC ϩ GF groups. Similarly, lessening of LV ␤1-adrenergic receptor transcripts following coronary occlusion was evenly restored toward control values by all three regenerative therapies. Although we did not attempt a detailed investigation of adrenoceptor changes in untreated and treated MI, our data collectively suggest that lowered proneness to arrhythmias ensuing the injection of GF-supplemented CPCs and GFs alone was not attributable to changes in the autonomic input to the heart.
Impact of CPC and CPC ϩ GF Administration on Basic Cardiac Electrophysiological Properties and Arrhythmogenic Substrate in Chronic MI
CPC repairing ability of cardiac electrical function was analyzed in terms of multicellular reentrant events rather than single-cell triggers. Indeed, data on the arrhythmogenic substrate of reentry at tissue level could represent important information, integrating single-cell results, which might be negatively influenced by the high degree of scattering of measurements, given the heterogeneous properties of the scarred myocardium.
Conduction velocity and anisotropy ratio. Numerous reports indicate that, during post-MI ventricular healing, in surviving myocytes of the border zone, there is continued reduction of Cx43, bringing about a decrease in functional gap junction connections (91) . Additional unfavorable effects on cell-to-cell contacts derive from fibrosis, which extends from the scar into viable border zones, mainly impairing transverse coupling (57) . These alterations can attain sufficient magnitude to lessen conduction velocity and generate enhanced nonuniform anisotropy, thus causing severe ventricular arrhythmias via reentry mechanisms (86) .
In most reports, the greater CV-l/CV-t anisotropy ratio in chronic MI is steadily linked to CV-t slowing, whereas CV-l contribution appears contradictory. This discrepancy was at- tributed to a different balance in the various experimental conditions between the parameters, which determine conduction, including connexin-mediated cell coupling, sodium conductance, and tissue architecture (86) . We found that enhanced anisotropy ratio in MI-V rats depended on slower CV-t associated with faster CV-l. Given that in spared cardiomyocytes of untreated MI hearts the cross-sectional area was about 1.5-fold greater than SO-T, the resulting changes in passive electrical properties would lead to a decline in intracellular longitudinal resistance, favoring electrical conduction along fibers and arguably contributing to accelerated CV-l (75) .
It is generally recognized that MI hearts contain a complex mixture of cells participating in infarct healing, including fibroblasts, which express the gap junctional protein Cx43 (12) and, thereby, might have contributed to the changes in the same protein observed in our study. Although we did not perform a detailed immunophenotypic characterization of the cell populations participating in MI, one would expect that the cellular pattern associated with the ischemic injury was grossly equivalent in treated and untreated MI animals, suggesting a little involvement of fibroblast contribution in Cx43 differences among the four MI groups. In support of this conclusion, measurements of Cx43 immunofluorescence signals, excluding the areas occupied by interstitial fibroblasts and coronary vasculature, displayed differences among treated and untreated MI rat hearts qualitatively similar to immunoblot studies.
By our data, CPC and CPC ϩ GF regenerative treatments brought back collagen deposition toward sham values, whereas a significant recovery of Cx43 expression against MI-V was shown in the sole animals subjected to injection of GFimplemented CPCs. In accordance with classical literature (32) , this difference might provide an explanation for the larger antiarrhythmic action of CPC ϩ GF compared with CPC. Indeed, curing the unfavorable changes in both Cx43-mediated cell coupling and interstitial fibrosis would improve conduction velocity (18, 60) , offsetting possible reentry pathways through the architectural structure of myocardial tissue. Nevertheless, we found a reduction rather than an increase of CV-l and CV-t in CPC ϩ GF animals vs. CPC, suggesting that other arrhythmogenic substrates/mechanisms were positively influenced by GF adjunct to CPCs, favoring its distinctive antiarrhythmic action.
Current-to-load mismatch areas and spread of excitation in myocardial tissue. Altered impulse propagation in the heart can also derive from structural discontinuities associated with unique cellular architecture of myocardial tissue, where the size of a given excited region supplying depolarizing current (current source) is ill matched to the amount of depolarizing current necessary to excite the regions ahead (current sink or current load) (32, 36) . In vitro studies documented that a small current source connected by gap junctions to a large current load can result in current-to-load mismatch that causes slowing of conduction velocity (62) . Surprisingly, partial uncoupling confined to the load area can lead to a reduction of the load accelerating conduction, whereas partial recoupling can be followed by a decline in conduction, attributable to a novel increase in the load. In the latter conditions, the contribution of ionic Ca ϩϩ current is critically important for the success of impulse propagation by sustaining depolarized transmembrane potentials, thereby increasing excitatory current flow to distant cells (61) .
In the border zone of chronic MI, long known examples of current-to-load mismatch are portrayed by surviving strands of myocytes connected to larger regions of viable tissue (83) . In our experimental settings, recovery of Cx43 expression promoted by regenerative treatments in such current mismatch zones was expected to induce partial recoupling, with decay in conduction velocity along fiber direction (CV-l) and further reduction of ventricular anisotropy ratio CV-l/CV-t, adding to the reduction caused by lower collagen deposition mentioned above. However, CPC ϩ GF treatment also increased the expression of Ca v 1.2 channel subunit at mRNA level and the related depolarizing current I Ca,L as likely expected outcomes, positively modulating impulse propagation, whereas CPCs alone did not. Therefore, the hypothesis is advanced that, in mismatch regions of the border zone, GF-implemented CPCs ameliorated intercellular connections while preventing an excessive decay in conduction velocity and blocks by a combined effect on the expression of Cx43 and ion channel subunit Ca v 1.2. These electrophysiological consequences could at least partly underlie the mechanisms of CPC ϩ GF-mediated antiarrhythmic action in the healed chronic MI. Furthermore, the Purkinje-fiber-ventricular junction represents another example for cardiac source-to-sink mismatch, where a small source (Purkinje fiber) is coupled to a large sink (mass of ventricular tissue) (55) . Of note, downstream from the His bundle, the conduction system of most mammals, including rats, prominently expresses Cx40, which concurs in determining cellular connections at the Purkinje/working ventricular myocyte interface (69) . So far, relatively little is known about how chronic MI influences expression of Cx40 and the consequent effects on spreading of excitation in the ventricular wall, although the importance of Cx40 in normal propagation has been recently emphasized (41) . We found that Cx40 expression, markedly reduced in MI-V rat hearts, was significantly restored by GFs and CPCs combined. It is conceivable that, for a given recovery in Ca v 1.2 transcript, Cx40 mediated recoupling in Purkinje fiber-ventricular junction regions, deteriorated by infarction, impinged on cardiac electrogenesis in a way similar to recoupling accomplished by Cx43 in working myocardium, concurring with the enhancement of the antiarrhythmic action of CPC ϩ GF administration.
Altogether, the favorable effect on cellular coupling and excitatory current flow, associated with restoring of Cx43, Cx40, and Ca v 1.2 expression in myocardial tissue, with or without structural discontinuities, appeared to be instrumental for the antiarrhythmic action of GF-implemented CPCs. Nevertheless, the effect of changes in cell-to-cell coupling and transmembrane Ca ϩϩ current cannot be considered independent of changes in other cellular/molecular determinants of arrhythmias mentioned above, similarly capable to affect electrical function in the highly interactive myocardial system. This will make it difficult to accurately predict the mechanisms of arrhythmogenesis and its prevention in any individual situation (32) .
Excitability and refractoriness. Most measurements related to these electrophysiological properties exhibited comparable values in MI-CPC and MI-CPC ϩ GF animals, suggesting a consequent minor role in the antiarrhythmic action of GFimplemented CPCs, despite the fact that we found several differences between the two regenerative treatments at the molecular level, which could influence both properties.
It is known that myocardial excitability is directly related to the total ionic inward current, which can exceed the repolarizing K current and myocyte cross-sectional area, and inversely related to interstitial fibrosis and gap junction resistivity (31) . In our study, the higher Rh and Chr values in MI-V rats than SO-T appeared to originate from the decline in total inward current as well as rise in collagen deposition and gap junction resistivity, which prevailed on the effects of the larger myocyte cross-sectional area. Rh and Chr changes were partially restored in a similar fashion by both regenerative treatments, notwithstanding the higher expression levels in MI-CPC ϩ GF animals of Ca v 1.2, in addition to Cx40 and even more Cx43. This might not be surprising, as the positive influence of increased depolarizing current I Ca,L on the threshold for tissue excitation could be counteracted by the greater electric load originating from better intercellular connections promoted by the two connexins, mentioned above.
Ventricular refractoriness and much more its spatially nonuniform distribution were increased in MI-V group compared with sham, in accordance with most studies (13) . Resetting of ERP dispersion to control values, induced by CPCs either alone or with GF adjunct, might be ascribed to the positive effects of both therapies on structural LV remodeling, helping to ameliorate the electrical stability of the regenerated heart. On the contrary, ERP persisted equally prolonged in MI-CPC and MI-CPC ϩ GF animals regardless of the finding that only GF-implemented CPCs cured the decline of Cx40 and Cx43 transcripts induced by MI, while fostering mRNA expression of channel proteins of ion current I Ca,L (Ca v 1.2) and I to (K v 4.2 and K v 4.3). However, ERP might be lengthened by the larger inward Ca ϩϩ current as well as connexin-mediated increased electrical load, and, on the other hand, it might be shortened by the enhanced outward K ϩ current. Taken together, our data suggest that the effects of CPCs with and without GF adjunct on the determinants of ventricular refractoriness may result in complex interactions and require further investigations.
Different Electrophysiological Consequences of Locally Injected GFs Alone and in Combination with CPCs
Administration of GFs alone exerted salubrious effects on cardiac electrical competence of healed MI with a significant drop in propensity to arrhythmias, in support of our previous results (6) . However, the arrhythmic risk in MI-GF rats was decreased to a lesser extent than MI-CPC ϩ GF, and the better ventricular electrical stability in the two animal groups com- pared with MI-V appeared to result from different electrophysiological mechanisms. It has been long recognized that arrhythmias can be treated largely by modulating conduction velocity, or refractory period, or both (29) . As mentioned above, GFimplemented CPCs reduced arrhythmia vulnerability by restoring toward control values ventricular CV-l/CV-t anisotropy ratio, at least partly attributable to a properly balanced resetting of Cx43, Cx40, and Ca v 1.2 expression (32, 61) . On the contrary, the individual injection of GFs led to a remarkable increase of ERP, in the absence of any changes on conduction velocity parameters compared with MI-V. This would prevent the occurrence of arrhythmias by prolonging the wavelength (i.e., the product of refractory period and CV) and eventually reducing the likelihood that a single or multiple reentrant circuit could originate in ventricular myocardium (87). Of note, this outcome was associated with a partial recovery of all but one of the transcripts deteriorated by the ischemic damage, suggesting a generalized, positive impact of GFs on most cellular/molecular determinants of cardiac electrogenesis. On the contrary, CPCs ϩ GFs had a more targeted influence on the same determinants, which might be more capable to achieve an optimal match between them, as required for local safe changes in CV and hence propagation of the impulse (31) . However, in accordance with the considerations made above on the effects of treatments on ERP, more work should be done to clarify how the numerous and in several instances opposite electrical influences, resulting from recovery of the various transcripts mediated by GFs, complemented each other. Also, it remains to be established how these influences led to the excitability/ refractoriness changes in GF animals documented in our study, including the persistence of high ERP dispersion.
Cx40 Expression in Ventricular Myocytes
Immunofluorescence and immunoblot data documenting the presence of Cx40 isoform in SO-T rat ventricles were unexpected because there is no published experimental evidence of a robust expression of this protein in normal adult, working ventricular cardiomyocytes. However, SO-T animals along with treated and untreated MI rats were subjected to several experimental procedures with an outcome on ventricular structural properties representing a situation different from a normal condition. As summarized in Fig. 2 , these procedures included the following: 1) three successive thoracotomies, with damage/removal of ventricular pericardium and predictable myocardial involvement; 2) microsurgery for coronary ligature or equivalent SO; and 3) intramyocardial injections for delivering specific treatments or vehicle. Moreover, positioning of the electrode grid at the ventricular surface in epicardial recording experiments generated injury currents at each electrode site lasting for about 30 min (40), indicative of a local damage. In general, one can anticipate that, by the above maneuvers, some degree of cell death occurred in ventricular myocardium of SO-T rats, conceivably followed by reactive cellular hypertrophy. Despite that Cx40 is less intensively characterized compared with Cx43 (65) , studies in hypertensive rats demonstrated a 3.1-fold increase in Cx40 expression compared with normal myocardium, during the early stage of hypertrophic remodeling (3). Similar results were obtained in explanted hearts from transplant patients with end-stage HF attributable to ischemic cardiomyopathy (20) . In both cases, the elevated Cx40 expression correlated with an increased depth of Cx40-expressing myocytes consistent with differentiation of working myocytes adjacent to Purkinje cells, developing conduction myocyte-type properties (20) . Alternatively, the changes have been attributed to expansion of the Purkinje system (68) . This cellular substrate can provide an explanation for the sizeable Cx40 expression documented in our studies in SO-T rat hearts. The ensuing differences among groups were likely resulting from the distinctive impact of GF, CPC, and CPC ϩ GF reparative treatments on the same substrate. Further complexity may be expected in the various MI groups against SO-T, deriving from reactive hypertrophy associated with the presence of scarred myocardial tissue and border zone areas, and, in treated MI rats, newly formed cardiomyocytes likely belonging to both working and conductive tissue. 
Cardiac Regeneration, Anatomy, and Mechanics
Chronic myocardial damage negatively conditions the activation, migration, and growth of CPCs, ultimately controlling the regenerative response of the pathological heart. It has been assumed that the loss of a chemokine/GF gradient within the healed myocardium may be responsible for the lack of endogenous repair despite an actual increase of tissue CPCs (58, 64, 82) . Our results on BrdU incorporation and Ki-67 labeling support the contention that more robust myocardial regeneration, compared with untreated MI, can be obtained via all three regenerative therapies, which may reverse the unfavorable microenvironment and promote the repairing ability of CPCs either resident or locally injected.
Information obtained in GFP pos CPC experiments indicated that GF adjunct favors CPC differentiation, resulting in more numerous Cx43-and Cx40-labeled cardiomyocytes within the infarcted area and at the border zone. These newly formed, electrically connected cells may represent a further mechanism of the observed reduction in ventricular arrhythmic events mediated by CPCs ϩ GFs. By these findings, GF-induced control of the expression of different types of connexins within the regenerated infarct offers an exciting explanation of the beneficial effects of the proposed repairing approach.
All regenerative treatments used in the present study were able to rescue, anatomically and mechanically, the infarcted heart. On the contrary, a divergent behavior was found between the overt positive consequences on electrical stability produced by GFs and further more CPCs ϩ GFs and the lack of parallel, additional recovery in cardiac mechanics and anatomy against CPCs alone. To date, no consensus exists on whether the repairing process mediated by CPCs as well as other stem cell populations in the infarcted heart results from direct or indirect mechanisms, i.e., differentiation of transplanted stem cells or paracrine factors secreted by the same cells (22, 23, 67, 84) . In keeping with the first hypothesis, the documented discrepancy of effects on cardiac mechanical and electrical properties might be linked to the fact that, although more contractile cells were generated within the infarct by GFs as well as CPCs ϩ GFs compared with CPCs only, the fully mature phenotype of newly formed cardiomyocytes was not achieved. In accordance with our previous observations, the volume of cardiomyocytes generated 2-3 wk after injection of rat or human CPCs (4, 5, 80) , GFs (6, 82) , or CPCs ϩ GFs (63, 64) ranges on average from 2,000 to 5,000 m 3 and does not reach that of adult cells (Ϸ25,000 m 3 ). Thus, it is conceivable that these regenerative processes, although advantageous, could not impact on detectable differences among treatments in the improvement of gross anatomic remodeling and global cardiac mechanics. Alternatively, by the "paracrine hypothesis" (26) , the better electrical performance in animals treated with GFs and, increasingly more, GF-supplemented CPCs vs. sole CPCs should depend on a complementary/synergistic role played by HGF and IGF-1 and their receptors, as important intermediates of cell-to-cell signaling, possibly related to the degree of CPC availability. In this case, our findings might suggest that HGF/IGF-1-mediated paracrine effects on cardiac function are more committed to restore the electrical than the mechanical and structural properties. Furthermore, the paracrine mechanisms involved appear to be different, depending on whether GFs were injected individually or in adjunct to CPCs, with a prevailing positive impact on cardiac refractoriness in the former case and conduction velocity in the latter. However, such an explanation requires additional complex experimental approaches.
Conclusions
Combined strategies that promote robust myocardial regeneration, local intercellular coupling, and ion channel reorganization ensue more efficient functional post-MI recovery. Further investigations are necessary to deeply understand the molecular and genetic mechanisms of the antiarrhythmic effect of GF adjunct in stem cell-mediated cardiac repair, as well as to exploit the potential of myocardial plasticity in restoring the multiple functional aspects of ischemic cardiomyopathy.
